Low Prevalence of Brucella agglutinins in Blood Donors in Central Province of Iran
Abstract
Background and Objective: Brucellosis is a zoonotic disease of worldwide distribution and has great economic importance. Despite its control in many countries, it remains endemic in Iran. Brucellosis was investigated in many high risk occupational groups; however, few studies on the prevalence of brucellosis among blood donors are available. To determine the seroprevalence of brucellosis antibodies in blood donors, a serological study was carried out in central province of Iran.
Materials and Methods: A total of 897 healthy blood donors with mean age 37.23 ± 10.9 years were enrolled in the study. Laboratory tests including Standard Tube Agglutination Test (STA) and 2-mercaptoethanol (2ME) agglutination were checked in all samples. STA dilution ≥ 1:80, and in the presence of 2-mercaptoethanol (2ME) agglutination ≥ 20 was considered positive.
Results: Out of 897 cases, 11.9% were inhabitants of rural areas. 41.5% had history of consumption of unpasteurized dairy products and 9.3% had history of contact with domestic animals. A very low level of Brucella agglutinins was present in 3(0.33%) of the samples and only one sample (0.11%) was found to be truly positive for Brucella agglutinins. 2ME was negative in all samples. None of these 4 subjects showed signs and symptoms of brucellosis in 6 months follow-up.
Conclusion: On the basis of our data, brucellosis has no epidemiological and clinical importance in our blood donors; therefore, it is not recommended to perform screening tests such as, STA and 2ME to identify brucellosis antibodies in the sera of blood donors.
Gur A, Geyik MF, Dikici B, Nas K, Cevik R, Sarac J, et al. Complications of brucellosis in different age groups: a study of 283 cases in southeastern Anatolia of Turkey. Yonsei Med J. 2003; 44: 33-44.
Sofian M, Aghakhani A, Velayati AA, Banifazl M, Eslamifar A, Ramezani A. Risk factors for human brucellosis in Iran: a case-control study. Int J Infect Dis 2008; 12: 157-161.
Bikas C, Jelastopulu E, Leotsinidis M, Kondakis X.Epidemiology of human brucellosis in a rural area of north-western Peloponnese in Greece. Eur J Epidemiol,2003;18: 267-274.
Me´ndez Martı´nez C, Pa´ez Jime´nez A, Corte´s-Blanco M, Salmoral Chamizo E, Mohedano Mohedano E, Plata C, et al. Brucellosis outbreak due to unpasteurized raw goat cheese in Andalucia (Spain), January—March 2002. Euro Surveill 2003; 8: 164-8.
Colmenero JD, Reguera JM, Martos F, Sa´nchez-De- Mora D, Delgado M, Causse M, et al. Complications associated with Brucella melitensis infection: A study of 530 cases. Medicine (Baltimore) 1996; 75: 195- 211.
Hasanjani MR, Mohrez M, Smailnejad SM, Soleimani MJ, Hajiahmadi M. Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, northern Iran. Epidemiol Infect 2004; 132: 1109-1114.
Afsar H, Baydar I, Sirmatel F. Epididymo-orchitis due to brucellosis. Br J Urol 1993; 72: 104-105.
Farahani SH, Shah Mohamadi S, Navidi I , Sofian M. An investigation of the epidemiology of brucellosis in Arak City, Iran, (2001-2010). Arak Medical University Journal 2012, 14: 49-54. [In Persian].
Collee JC, Dugid JP, Fraser AG, Marmion BP. Mackie & McCartney Practical Medical Microbiology, Churchill Livingstone, New York,1989. p. 529.
Gwida M, Al DS, Melzer F, Rosler U, Neubauer H, Tomaso H. Brucellosis - regionally emerging zoonotic disease? Croat Med J 2010; 51: 289-295.
Nikokar I, Hosseinpour M, Asmar M, Pirmohbatei S, Hakeimei F, Razavei MT. Seroprevalence of B rucellosis among high risk individuals in Guilan, Iran. J Res Med Sci 2011; 16: 1366-1371.
Al-Majali AM, Talafha AQ, Ababneh MM, Ababneh MM. Seroprevalence and risk factors for bovine brucellosis in Jordan. J Vet Sci 2009; 10:61-65.
Yoo SJ, Choi YS, Lim HS, Lee K, Park MY, Chu C, et al. [Seroprevalence and risk factors of brucellosis among slaughterhouse workers in Korea J Prev Med Public Health. 2009; 42: 237-242.
Beheshti S, Rezaian GR, Azad F, Faghiri Z, Taheri F. Seroprevalence of brucellosis and risk factors related to high risk occupational groups in kazeroon, South of Iran. Int J Occup Environ Med 2010; 1:62-68.
Muhammad N, Hossain MA, Musa AK, Mahmud MC, Paul SK, Rahman MA, , et al. Seroprevalence of human brucellosis among the population at risk in rural area. Mymensingh Med J 2010; 19: 1-4.
Mukhtar F, Kokab F. Brucella serology in abattoir workers. J Ayub Med Coll Abbottabad 2008; 20:57-61.
Swai ES, Schoonman L. Human brucellosis: seroprevalence and risk factors related to high risk occupational groups in Tanga Municipality, Tanzania. Zoonoses Public Health 2009; 56:183-187.
Bhat K, Hemashettar, BM, Jain R, Anrade AT, Patil CS. Latex agglutination test for antigen detection in human brucellosis. Indian J Med Microbiol 1997; 15: 210.
Ajay Kumar VJ, Nanu E. Sero-positivity of brucellosis in human beings. Indian J Public Health 2005; 49: 22-24.
Torres-Padilla JC, López-Merino A, García- Escamilla RM, Gutiérrez-García JN. Anti- Brucella antibody seroprevalence in blood dono- rs for therapeutic ends at three blood banks of the Mexican Institute of Social Security. Gac Med Mex 2004; 140: 391-398.
Vaishnavi C, Kumar S. Investigation for back- ground prevalence of Brucella agglutinins among blood donors. Indian J Med Microbiol 2007; 25:302-304.
Ghilian R, Hekmati Moghaddam SH, Fatemi A, Eslamieh H, Dargahi M. Seroepidemiologic status of brucellosis in blood donors in Yazd, 2009. Sci J Blood Transfus Organ 2011; 7 : 196-205.
Rabbani Khorasgani M, Esmaeili H, Pourkarim MR, Mankhian AR, Zahraei Salehi T. Anti- brucella antibodies in blood donors in Boushehr, Iran. Comp Clin Pathol 2008; 17: 267-269.
Files | ||
Issue | Vol 5 No 1 (2013) | |
Section | Articles | |
Keywords | ||
Brucella agglutinins Brucellosis blood donors |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |